The COVID-19 outbreak has shocked the social and economic structures worldwide. Amid globalization, diseases spread rapidly and far, through international trade and travel. The dramatic numbers of deaths have been accompanied by collateral damage, mainly a sanitary and socio-economic crisis. The present situation is further aggravated by the infodemic, the mismanagement of national governments and an increasing mistrust in health institutions. This global health emergency has disproportionately affected Barbados and the Eastern Caribbean, where fragile health systems fight a critical  socioeconomic context1. However, in just 333 days the international community was able to develop the first dose of the COVID-19 vaccine. Today, efforts are being concentrated in order to produce and distribute the vaccines to low- and middle-income countries.

Worldwide, the epidemiological situation varies quickly, and as of the closing of this report, the international community deals with the expansion of the new COVID-19 variant, Omicron. Although we still do not have conclusive and definite data on this new variant, early research suggests that it is more contagious than previous ones, and possibly causes a less severe infection2. Still, a significant increase in cases, even with a smaller percentage of hospitalisations, could cause an overload to the health system, which makes vaccination the best tool to control the current situation and those to come. Hence, the objective of this document is to assess the current situation in Barbados and the Eastern Caribbean regarding COVID-19 vaccination and its socioeconomic impact to identify good practices to boost vaccination rates and therefore, contribute to their economic recovery.